Zeev Bovan
Posts (688)
I was thinking to buy again at 120&$ but Jesus h Christ where is the bottom?! Is Orcle going bankrupt?!
Here’s a plain-English interpretation and prediction based on the note you shared about Protara Therapeutics and the upcoming data release at ASCO-GU.
What this means for TARA stock next week
? Bullish scenario (best case)
If the interim data show results similar to the earlier BCG-naive results, the stock could move significantly higher.
Why:
Investors want to see ~70% complete response (CR) at 6 months and ~50% at 12 months.
That would put TARA-002 competitive with leading bladder-cancer drugs, including programs from CG Oncology and Johnson & Johnson.
Larger patient numbers (around 25 patients) make the data more credible than the earlier tiny sample.
Possible analyst initiations after the data (e.g., big banks starting coverage) can push the stock higher.
? In biotech terms, if results hit the company’s hinted levels, it could cause a re-rating (often 30–100%+ moves aren’t unusual).
? Neutral / modest outcome
If results are:
~60% CR at 6 months
~40% CR at 12 months
The report suggests the drug is still competitive, especially because:
Better safety
Easier administration
In this case:
The stock might rise slightly or stay volatile rather than explode upward.
? Bearish scenario
The biggest risks:
Data comes in much lower than expected
Safety issues appear
Response rates fall well below competitors
That could cause:
A sharp drop, because biotech stocks often move heavily on trial results.
Key dates to watch
Feb 23: Abstract release (initial data snapshot)
Feb 27: Full poster presentation (possibly more patients and updated results)
These dates could trigger big price moves in TARA.
✅ Overall prediction (based on this note and typical biotech behavior):
The stock is entering a binary catalyst event.
Expectations appear moderately high but not extreme, which means:
Strong data → large rally
Average data → mild upside or mixed reaction
From hero to zero, not for the faint of heart
Keep buying the dips and you won’t have money left to buy it when it finally hit rock bottom.
